Department of Microbiology and Immunology, Southeast University Medical School, Nanjing, Jiangsu, China.
Immunol Lett. 2013 Feb;150(1-2):1-11. doi: 10.1016/j.imlet.2013.01.003. Epub 2013 Jan 14.
Cell-free artificial antigen-presenting cells (aAPCs) were generated by coupling H-2K(b)/TRP2 tetramers together with anti-CD28 and anti-4-1BB antibodies onto cell-sized latex beads and injected intravenously and subcutaneously into naïve mice and antigen-primed mice (B6, H-2K(b)). Vigorous tumor antigen-specific CTL responses in the native T-cell repertoire in each mouse model were elicited as evaluated by measuring surface CD69 and CD25, intracellular IFN-γ, tetramer staining and cytolysis of melanoma cells. Furthermore, the aAPCs efficiently inhibited subcutaneous tumor growth and markedly delayed tumor progression in tumor-bearing mice. These data suggest that bead-based aAPCs represent a potential strategy for the active immunotherapy of cancers or persistent infections.
无细胞人工抗原呈递细胞(aAPCs)通过将 H-2K(b)/TRP2 四聚体与抗 CD28 和抗 4-1BB 抗体偶联到细胞大小的乳胶珠上,并静脉内和皮下注射到 naive 小鼠和抗原 primed 小鼠(B6,H-2K(b))中生成。通过测量表面 CD69 和 CD25、细胞内 IFN-γ、四聚体染色和黑色素瘤细胞的细胞溶解来评估每个小鼠模型中天然 T 细胞库中的强烈肿瘤抗原特异性 CTL 反应。此外,aAPCs 有效地抑制了荷瘤小鼠的皮下肿瘤生长并显著延迟了肿瘤进展。这些数据表明,基于珠的 aAPCs 代表了癌症或持续性感染的主动免疫治疗的一种潜在策略。